FLGT logo

FLGT

Fulgent Genetics Inc.

$22.17
+$0.14(+0.64%)
59
Overall
60
Value
58
Tech
--
Quality
Market Cap
$657.18M
Volume
348.55K
52W Range
$14.57 - $23.56
Target Price
$25.33
Order:

Income Statement

MetricTrendChart
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$18.3M$18.7M$21.4M$32.5M$421.7M$992.6M$619.0M$289.2M$283.5M
Total Revenue
$18.3M$18.7M$21.4M$32.5M$421.7M$992.6M$619.0M$289.2M$283.5M
COST OF GOODS SOLD
Cost of Revenue
$-6.7M$-8.6M$-10.7M$14.1M$89.8M$215.5M$252.1M$184.8M$176.3M
GROSS PROFIT
Gross Profit
$11.6M$10.2M$10.7M$18.4M$331.9M$777.1M$366.9M$104.5M$107.2M
OPERATING EXPENSES
Operating Expenses
$-10.6M$-13.7M$-15.7M$18.8M$41.7M$101.1M$188.4M$300.0M$181.1M
Research & Development
$3.6M$4.2M$5.5M$6.5M$11.6M$24.2M$28.9M$41.4M$48.8M
Research Expense
$3.6M$4.2M$5.5M$6.5M$11.6M$24.2M$28.9M$41.4M$48.8M
Selling, General & Administrative
$7.1M$9.4M$10.2M$26.4M$120.0M$75.2M$150.0M$130.5M$124.4M
Selling & Marketing Expenses
$2.5M$4.2M$4.7M$5.9M$104.8M$24.4M$38.9M$41.5M$36.2M
General & Administrative Expenses
$4.6M$5.2M$5.5M$20.5M$15.2M$50.7M$111.1M$89.0M$88.1M
Salaries & Wages
$-4.7M$-2.1M$-2.3M$-3.2M----------
Depreciation & Amortization
$-1.2M$-1.7M$-2.2M$2.1M$3.0M$1.7M$6.5M$7.8M$8.0M
Depreciation & Amortization
$-1.2M$-1.7M$-2.2M$2.1M$3.0M$1.7M$6.5M$7.8M$8.0M
Amortization
----------$1.7M$6.5M$7.8M$8.0M
Other Operating Expenses
$-10.6M$-13.7M$-15.7M$18.8M$-236.0K$-333.0K$188.4M----
OPERATING INCOME
Operating income
$918.0K$-3.5M$-5.1M$-428.0K$290.2M$676.0M$178.5M$-195.5M$-73.9M
EBITDA
$-3.2M$-903.0K$-2.2M$2.6M$293.1M$687.0M$216.7M$-141.0M$-23.4M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
--------$20.0K$117.0K--$488.0K$-170.0K
Intinc
----$434.0K$837.0K$1.5M$1.3M$5.5M$21.6M$31.3M
Net Non-Operating Interest Income/Expense
----$434.0K$837.0K$1.5M$1.3M$5.5M$21.1M$31.5M
Gain on Sale of Securities
$163.0K$164.0K$104.0K$32.0K$131.0K--------
Other Income/Expense
$5.4M$524.0K$935.0K$777.0K$488.0K$-27.9M$-3.0M$-320.0K$-561.0K
Other Special Charges
----$16.0K$59.0K$257.0K$26.4M--$320.0K$561.0K
SPECIAL ITEMS
Restructring And Mn A Income
------------$3.0M----
Special Income Charges
----------$-215.5M$-3.0M$-120.2M--
Impairment of Capital Assets
----------$215.5M--$120.2M--
PRE-TAX INCOME
EBIT
$-4.5M$-3.0M$-4.6M$409.0K$290.2M$676.0M$184.0M$-173.6M$-52.1M
Pre-Tax Income
$-4.5M$-3.0M$-4.6M$409.0K$291.7M$677.3M$184.0M$-174.1M$-52.0M
INCOME TAX
Tax Provision
$920.0K$-1.0M$36.0K$43.0K$72.5M$174.8M$42.1M$1.2M$-8.1M
NET INCOME
Net Income
$-5.4M$-2.5M$-5.6M$-411.0K$214.3M$507.4M$143.4M$-167.8M$-42.7M
Net Income (Continuing Operations)
$-5.4M$-2.5M$-5.6M$-411.0K$214.3M$507.4M$141.9M$-175.2M$-43.8M
Net Income (Discontinued Operations)
$-5.4M$-2.5M$-5.6M$-411.0K$214.3M$507.4M$143.4M$-167.8M$-42.7M
Net Income (Common Stockholders)
$-5.4M$-2.5M$-5.6M$-411.0K$214.3M$507.4M$143.4M$-167.8M$-42.7M
TOTALS
Total Expenses
$-17.4M$-22.2M$-26.4M$33.0M$131.6M$316.6M$440.4M$484.7M$357.4M
SHARE & EPS DATA
Average Shares Outstanding
$13.7M$17.7M$18.0M$18.7M$22.7M$29.4M$30.1M$29.8M$30.2M
Average Shares Outstanding (Diluted)
$107.8M$17.7M$18.0M$18.7M$24.1M$31.0M$31.0M$29.8M$30.2M
Shares Outstanding
$17.7M$17.9M$18.3M$21.6M$28.9M$30.3M$29.5M$29.8M$30.8M
Basic EPS
$0.05$-0.09$-0.11$-0.02$9.44$17.25$4.76$-5.63$-1.41
Basic EPS (Continuing Operations)
--$-0.14$-0.31$-0.02$9.44$17.25$4.76$-5.63$-1.41
Diluted EPS
$0.05$-0.09$-0.11$-0.02$8.91$16.38$4.63$-5.63$-1.41
Diluted EPS (Continuing Operations)
--$-0.14$-0.31$-0.02$8.91$16.38$4.63$-5.63$-1.41
OTHER METRICS
Accretion On Preferred Stock
$-4.6M----------------
Acquired In Process Rn D Income
$-5.4M----------------
Commission Expenses
--------$89.8M--------
Cumulative Effect Of Accounting Change
----------$239.0K------
Earnings from equity interest
--$-524.0K$-935.0K$-777.0K$-488.0K--------
Earnings From Equity Interest Net Of Tax
--$-524.0K$-935.0K$-777.0K$-488.0K--------
Gain On Sale Of Business
--$481.0K--------------
Minority Interests
--------$569.4M$1.1M$1.5M$7.4M$1.1M
Net Income Discontinuous Operations
$400.0K----------------
Net Income From Other Gains Losses
--------$-4.4M$3.7M------
Other Gand A
$4.6M$5.2M$5.5M$20.5M$15.2M$50.7M$111.1M$89.0M$88.1M
Other Impairment Of Capital Assets
--------$4.4M--------
Other Write Off
$-27.0K$-24.0K$-6.0K$28.0K$23.0K$499.0K------
Otherunder Preferred Stock Dividend
$-4.6M----------------
Preferred Stock Dividends
$-4.6M----------------
Realized Capital Gain
----$434.0K------------
Rent And Landing Fees
$4.6M$5.2M$5.5M------------
Selling Expense
$2.5M$4.2M$4.7M$5.9M----------
Write Off
----------$215.5M------
Restruct
------------$3.0M----

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2FLGT$22.17+0.6%348.55K
3
4
5
6

Get Fulgent Genetics Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.